The role of lymphadenectomy in node-positive epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 6, 2012, Pages 987-992

  Pereira, Augusto ^a,b   Pérez Medina, Tirso ^b   Magrina, Javier F ^a   Magtibay, Paul M ^a   Millan, Isabel ^b   Iglesias, Enrique ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Advanced epithelial ovarian cancer; Prognostic factors; Survival; Therapeutic role pelvic and aortic lymphadenectomy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; AORTIC LYMPHADENECTOMY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PERITONEUM METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; AORTA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PELVIS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84863613557     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318257b958     Document Type: Review

References (18)

1. Winter WE 3rd, Maxwell GL, Tian C, et al. Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621-3627.
2. du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer. 2009;115:1234-1244.
3. Eisenkop SM, Spirtos NM, Friedman RL, et al. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90:390-396.
4. Benedet JL, Pecorelli S. Why cancer staging? Int J Gynecol Obstet. 2006;95:S3.
5. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95: S161YS192.
6. Benedetti Panici P, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560-566.
7. Harrell FE Jr. (2001b) Re: (S) model fitting with logistic regression. S-news@list.biostat.wustl.edu. April 6, 2011.
8. Hosmer DW, Lemeshow S. Applied Logistic Regression. Wiley-Interscience. 2000.
9. Wimberger P, Kimmig R. The role of radical lymphadenectomy. Experiences from the AGO Ovarian Cancer Study Group. Urologe A. 2009;48:26-31.
10. Morice P, Pautier P, Lhommé C, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: a randomized clinical trial. JNCI J Natl Cancer Inst. 2005;97:1620-1621.
11. Rouzier R, Bergzoll C, Brun JL, et al. The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database. BJOG. 2010;117:1441-1443.
12. Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96:1817-1822.
13. du Bois A, Reuss A, Harter P, et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). J Clin Oncol. 2010;28: 1733-1739.
14. Kim HS, Ju W, Jee BC, et al. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis. Int J Gynecol Cancer. 2010;20:520-528.
15. Isonishi S, Niimi S, Sasaki H, et al. Drug sensitivityYrelated benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer. Gynecol Oncol. 2004;93:647-652.
16. Benedetti Panici P, Perniola G, Angioli R, et al. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery. Int J Gynecol Cancer. 2007;17: 1245-1251.
17. Cliby WA, Aletti GD, Wilson TO, et al. Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006;103:781-782.
18. Pereira A, Magrina JF, Magtibay PM, et al. The impact of peritoneal metastases in epithelial ovarian cancer with positive nodes. Int J Gynecol Cancer. 2011;21:1375-1379.